Literature DB >> 16461472

Treating vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline?

K Alagiakrishnan1, P McCracken, H Feldman.   

Abstract

Dementia is a progressive disorder that typically worsens with time and from which recovery is unlikely. The incidence of dementia increases exponentially with ageing and is an important public health challenge. There is now growing evidence for the role of vascular factors in Alzheimer's disease, mixed dementia (Alzheimer's disease with cerebrovascular disease), and of course vascular dementia. With the rising prevalence of vascular disease, there are increasing numbers of people who are identified to be at risk of cognitive impairment. By changing modifiable vascular risk factors, there is emerging evidence that it may be possible to prevent or delay the expression and progression of dementia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461472      PMCID: PMC2596696          DOI: 10.1136/pgmj.2005.035030

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  51 in total

1.  Leisure activities and the risk of dementia in the elderly.

Authors:  Joe Verghese; Richard B Lipton; Mindy J Katz; Charles B Hall; Carol A Derby; Gail Kuslansky; Anne F Ambrose; Martin Sliwinski; Herman Buschke
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

2.  Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial.

Authors:  Mikael Simons; Frank Schwärzler; Dieter Lütjohann; Klaus von Bergmann; Konrad Beyreuther; Johannes Dichgans; Henning Wormstall; Tobias Hartmann; Jörg B Schulz
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

3.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

Review 4.  Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies.

Authors:  S Kalmijn
Journal:  J Nutr Health Aging       Date:  2000       Impact factor: 4.075

5.  Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease.

Authors:  Annalena Venneri; Michael F Shanks; Roger T Staff; Simon J Pestell; Katrina E Forbes; Howard G Gemmell; Alison D Murray
Journal:  Neuroreport       Date:  2002-01-21       Impact factor: 1.837

6.  Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project.

Authors:  Hui-Xin Wang; Anita Karp; Bengt Winblad; Laura Fratiglioni
Journal:  Am J Epidemiol       Date:  2002-06-15       Impact factor: 4.897

Review 7.  Antioxidant strategies for Alzheimer's disease.

Authors:  Michael Grundman; Michael Grundman; Patrick Delaney
Journal:  Proc Nutr Soc       Date:  2002-05       Impact factor: 6.297

8.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

9.  Vitamin E and cognitive decline in older persons.

Authors:  Martha Clare Morris; Denis A Evans; Julia L Bienias; Christine C Tangney; Robert S Wilson
Journal:  Arch Neurol       Date:  2002-07

Review 10.  Statins in the prevention and treatment of Alzheimer disease.

Authors:  Milita Crisby; Lars A Carlson; Bengt Winblad
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Jul-Sep       Impact factor: 2.703

View more
  8 in total

1.  Classification models for early identification of persons at risk for dementia in primary care: an evaluation in a sample aged 80 years and older.

Authors:  Tessa N van den Kommer; Daniel E Bontempo; Hannie C Comijs; Scott M Hofer; Miranda G Dik; Andrea M Piccinin; Cees Jonker; Dorly J H Deeg; Boo Johansson
Journal:  Dement Geriatr Cogn Disord       Date:  2009       Impact factor: 2.959

Review 2.  Imaging small vessel-associated white matter changes in aging.

Authors:  D H Salat
Journal:  Neuroscience       Date:  2013-12-06       Impact factor: 3.590

3.  Development of classification models for early identification of persons at risk for persistent cognitive decline.

Authors:  T N van den Kommer; H C Comijs; M G Dik; C Jonker; D J H Deeg
Journal:  J Neurol       Date:  2008-07-14       Impact factor: 4.849

4.  Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II study.

Authors:  Séverine Sabia; Hermann Nabi; Mika Kivimaki; Martin J Shipley; Michael G Marmot; Archana Singh-Manoux
Journal:  Am J Epidemiol       Date:  2009-07-02       Impact factor: 4.897

5.  The use of N-terminal pro-brain natriuretic Peptide to evaluate vascular disease in elderly patients with mental illness.

Authors:  Karin Nilsson; Lars Gustafson; Björn Hultberg
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-02-03

6.  Exercise training improves vascular function in patients with Alzheimer's disease.

Authors:  Anna Pedrinolla; Massimo Venturelli; Cristina Fonte; Stefano Tamburin; Angela Di Baldassarre; Fabio Naro; Valentina Varalta; Gaia Giuriato; Barbara Ghinassi; Ettore Muti; Nicola Smania; Federico Schena
Journal:  Eur J Appl Physiol       Date:  2020-07-30       Impact factor: 3.078

Review 7.  Psychiatric disorders and risk of subsequent dementia: Systematic review and meta-analysis of longitudinal studies.

Authors:  Jean Stafford; Wing Tung Chung; Andrew Sommerlad; James B Kirkbride; Robert Howard
Journal:  Int J Geriatr Psychiatry       Date:  2022-04-11       Impact factor: 3.850

8.  HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression.

Authors:  Yao-Ching Fang; Lung Chan; Jing-Ping Liou; Yong-Kwang Tu; Mei-Jung Lai; Chin-I Chen; Amelia Nur Vidyanti; Hsueh-Yun Lee; Chaur-Jong Hu
Journal:  J Cell Mol Med       Date:  2020-05-06       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.